At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
In Brief
An observational study for Acute Lymphoblastic Leukemia. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The purpose of the study is to determine the utility of XCL1 in the prognosis of acute lymphoblastic leukemia.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Lymphoblastic Leukemia
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedJun 2011
Primary CompletionSep 2012
TodayJul 2026
First PostedJun 27, 2011
Enrollment StartNov 1, 2010
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.0 years ago